Form 4: Cardinal Health Executive Deborah Weitzman Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Deborah Weitzman, CEO of PSS Segment at Cardinal Health, reports acquisition and disposal of company shares to cover tax obligations and vesting of restricted stock units.

Summary

  • Deborah Weitzman, CEO of the PSS Segment at Cardinal Health, filed a Form 4 detailing changes in beneficial ownership.
  • On August 15, 2024, she disposed of 9,918 common shares at $106.36 to cover tax obligations related to vesting restricted share units (RSUs) and performance share units.
  • Also on August 15, 2024, she acquired 13,530 common shares through the grant of RSUs, which vest in three equal annual installments starting August 15, 2025.
  • On August 16, 2024, she disposed of 2,341 common shares at $107.91 to cover tax obligations related to vesting RSUs.
  • Following these transactions, Weitzman directly owns 49,761 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transactions are routine and related to compensation and tax obligations. There is no indication of unusual or concerning activity.

Positives

  • The grant of 13,530 RSUs indicates continued investment in the executive's long-term performance.

Future Outlook

The RSUs granted on August 15, 2024, vest in three equal annual installments beginning on August 15, 2025, indicating a multi-year incentive structure.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation and tax planning. These transactions provide insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Executive compensation packages often include stock options, restricted stock units, and performance share units to align management's interests with those of shareholders.
  • The vesting schedules and tax withholding practices observed in this filing are typical for publicly traded companies like Cardinal Health, and are similar to those of competitors such as McKesson and AmerisourceBergen.

Stakeholder Impact

  • The transactions themselves have minimal direct impact on stakeholders.
  • However, the vesting of RSUs and performance share units aligns executive compensation with company performance, which indirectly benefits shareholders.

Key Dates

DateDescription
08/15/2024Disposal of 9,918 shares for tax obligations and acquisition of 13,530 shares through RSU grant.
08/15/2025First vesting date for the granted RSUs.
08/16/2024Disposal of 2,341 shares for tax obligations.
08/19/2024Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.